Skip to content
How It Works
Explore
Ask a Question Resources Pricing
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Ask a Question
PubMed This is a summary of 8 peer-reviewed journal articles Updated
Obstetrics · MTHFR 677TT Genotype

The MTHFR Connection: Riboflavin and Your Blood Pressure

At a Glance

For individuals with the MTHFR 677TT genotype, the MTHFR enzyme is less stable and can increase the risk of high blood pressure. Taking targeted riboflavin (Vitamin B2) supplements acts as an enzyme stabilizer, which has been shown to significantly lower systolic blood pressure.

For most people, riboflavin (Vitamin B2) is simply a vitamin needed for energy. However, for those with a specific genetic variation called the MTHFR 677TT genotype, riboflavin acts as a crucial “stabilizer” for a key enzyme that regulates blood pressure [1][2]. Understanding this gene-nutrient interaction can help you and your care team personalize your prenatal nutrition to support healthy blood pressure throughout your pregnancy.

The Science: Riboflavin as an Enzyme Stabilizer

The MTHFR enzyme (methylenetetrahydrofolate reductase) plays a vital role in one-carbon metabolism, a series of chemical reactions essential for DNA repair and cellular health [2][3]. To work correctly, this enzyme requires a form of riboflavin called FAD (flavin adenine dinucleotide) as a helper [4].

In individuals with the 677TT genotype, the MTHFR enzyme is less stable and “loses” its riboflavin helper more easily than in other people [1]. This instability leads to:

  • Reduced Enzyme Activity: The enzyme works less efficiently, which can disrupt metabolism [5].
  • Higher Homocysteine: Poor enzyme function can lead to elevated levels of homocysteine, an amino acid linked to cardiovascular stress [6][5].
  • Increased Blood Pressure: This genetic variant is independently linked to a higher risk of hypertension (high blood pressure) [5][7].

What the Research Shows

Clinical trials have explored whether providing extra riboflavin can “rescue” the unstable MTHFR enzyme in people with the 677TT genotype. The results have been significant:

  • Blood Pressure Reduction: In multiple trials, targeted riboflavin supplementation (often at a dose of 1.6 mg/day) lowered systolic blood pressure (the top number) by 6 to 13 mmHg specifically in 677TT carriers [1].
  • Genotype Specificity: This blood-pressure-lowering effect was not seen in people with the more common ‘CC’ or ‘CT’ genotypes, highlighting a truly personalized nutritional response [1].
  • Medication Independence: The effect was observed even in individuals who were already taking blood pressure medications, suggesting that riboflavin works through a unique biological pathway [1].

Riboflavin and Preeclampsia Concerns

Because riboflavin helps regulate blood pressure in MTHFR 677TT carriers, researchers are investigating its role in preventing hypertensive disorders of pregnancy, such as preeclampsia [8]. While preeclampsia is a complex condition with many causes, maintaining optimal riboflavin status is increasingly viewed as a promising “personalized solution” for women with this specific genetic risk [8][5].

It is important to note that major medical organizations like the American College of Obstetricians and Gynecologists (ACOG) do not currently mandate high-dose riboflavin specifically for preeclampsia prevention [8]. However, ensuring you meet the recommended intake for your genotype is a low-risk strategy that supports your cardiovascular health [5].

Personalized Nutrition for 677TT Carriers

If you have the MTHFR 677TT genotype, your riboflavin needs may be higher than the standard Recommended Dietary Allowance (RDA) for pregnancy [1].

  • Supplementation: Trials showing blood pressure benefits often used a dose of 1.6 mg/day, which is slightly higher than the standard pregnancy RDA of 1.4 mg [1][4].
  • Status Monitoring: Working with your doctor to monitor both your blood pressure and your overall riboflavin status (using tests like EGRAC) can help you tailor your intake [4].

By ensuring your “helper” (riboflavin) is always available to stabilize your enzyme, you can actively support your body’s ability to maintain healthy blood pressure [5].

Return to Guide Overview

Common questions in this guide

How does the MTHFR 677TT genotype affect my blood pressure?
This genetic variation makes the MTHFR enzyme less stable and less efficient. Poor enzyme function can elevate homocysteine levels in your blood, which increases cardiovascular stress and raises your independent risk of developing high blood pressure.
Can taking riboflavin help lower my blood pressure?
Yes, clinical trials show that targeted riboflavin supplementation can lower systolic blood pressure by 6 to 13 mmHg specifically in people with the MTHFR 677TT genotype. Riboflavin acts as a stabilizer for the enzyme, helping it work correctly even if you are already taking blood pressure medication.
How much riboflavin do I need if I have the MTHFR 677TT genotype?
Studies demonstrating blood pressure benefits often use a daily dose of 1.6 mg of riboflavin. Because this is slightly higher than the standard pregnancy recommendation of 1.4 mg, you should discuss your prenatal vitamin formulation and personalized dosing with your doctor.
Does riboflavin prevent preeclampsia in MTHFR carriers?
While major medical organizations do not currently mandate high-dose riboflavin to prevent preeclampsia, researchers view it as a promising strategy for women with the MTHFR 677TT genotype. Ensuring you have adequate riboflavin levels is a low-risk way to support cardiovascular health during pregnancy.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Am I positive for the MTHFR 677TT genotype, and if so, how does that affect my risk for high blood pressure during this pregnancy?
  2. 2.Based on recent clinical trials, would a targeted dose of 1.6 mg of riboflavin daily be appropriate for my specific genotype?
  3. 3.Does my current prenatal vitamin provide enough riboflavin (Vitamin B2) to support my MTHFR enzyme function?
  4. 4.How often will we be monitoring my blood pressure given my genetic predisposition for hypertension?
  5. 5.Are you familiar with the research showing that riboflavin can lower systolic blood pressure by 6–13 mmHg in individuals with my specific MTHFR variant?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (8)
  1. 1

    Riboflavin, MTHFR genotype and blood pressure: A personalized approach to prevention and treatment of hypertension.

    McNulty H, Strain JJ, Hughes CF, Ward M

    Molecular aspects of medicine 2017; (53()):2-9 doi:10.1016/j.mam.2016.10.002.

    PMID: 27720779
  2. 2

    Impact of the MTHFR C677T polymorphism on one-carbon metabolites: Evidence from a randomised trial of riboflavin supplementation.

    Rooney M, Bottiglieri T, Wasek-Patterson B, et al.

    Biochimie 2020; (173()):91-99 doi:10.1016/j.biochi.2020.04.004.

    PMID: 32330571
  3. 3

    Vitamin B-6 and riboflavin, their metabolic interaction, and relationship with MTHFR genotype in adults aged 18-102 years.

    Jarrett H, McNulty H, Hughes CF, et al.

    The American journal of clinical nutrition 2022; (116(6)):1767-1778 doi:10.1093/ajcn/nqac240.

    PMID: 36264281
  4. 4

    Riboflavin status, MTHFR genotype and blood pressure: current evidence and implications for personalised nutrition.

    McAuley E, McNulty H, Hughes C, et al.

    The Proceedings of the Nutrition Society 2016; (75(3)):405-14 doi:10.1017/S0029665116000197.

    PMID: 27170501
  5. 5

    Impact of the common MTHFR 677C→T polymorphism on blood pressure in adulthood and role of riboflavin in modifying the genetic risk of hypertension: evidence from the JINGO project.

    Ward M, Hughes CF, Strain JJ, et al.

    BMC medicine 2020; (18(1)):318 doi:10.1186/s12916-020-01780-x.

    PMID: 33172445
  6. 6

    Association study of methylenetetrahydrofolate reductase C677T mutation with cerebral venous thrombosis in an Iranian population.

    Ghaznavi H, Soheili Z, Samiei S, Soltanpour MS

    Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2015; (26(8)):869-73 doi:10.1097/MBC.0000000000000292.

    PMID: 26083986
  7. 7

    The relationship between riboflavin and hypertension with MTHFR C677T in older adults in northern China: a case-control study.

    Zhang L, Wang Z, Wu T, et al.

    Asia Pacific journal of clinical nutrition 2025; (34(4)):619-626 doi:10.6133/apjcn.202508_34(4).0013.

    PMID: 40738729
  8. 8

    Can riboflavin offer a novel personalised strategy for maintaining healthy blood pressure in pregnancy in populations globally?

    Duffy B, Patted A, Boelig RC, et al.

    BMJ nutrition, prevention & health 2025; (8(2)):e001212 doi:10.1136/bmjnph-2025-001212.

    PMID: 41768514

This page provides educational information about the MTHFR gene and riboflavin. It does not replace professional medical advice, so please consult your obstetrician before changing your prenatal supplements or diet.

Get notified when new evidence is published on Maternal riboflavin deficiency.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.